
SOTS 2nd Hour: The Disney Breakdown: Plus CFO Hugh Johnston, Pharma Risks Loom, and Taylor Morrison CEO 5/7/25
Squawk on the Street
00:00
Disney's Strong Financial Performance and Pharma Challenges
This chapter analyzes the performance of pharmaceutical shares following new FDA leadership and delves into Disney's impressive financial results and upcoming Abu Dhabi resort plans. It highlights Disney's surpassed earnings expectations and the impact of geopolitical tensions on its Shanghai operations.
Transcript
Play full episode